A consistent and strong positive correlation between Bcl-2 positivity and hormone receptor expression is reported in breast cancer, and concerns both ER and PR [7, 9, 12, 19, 49, 51, 52, 54, 55, 58–60]. This evidence concerns the gene NR4A1 and breast cancer.